Bolni Nagalo, PhD, Appointed Associate Professor of Pharmacology and Physiology at UMSOM

The University of Maryland School of Medicine (UMSOM) is pleased to welcome Bolni M. Nagalo, MSc, PhD, who has been appointed Associate Professor of Pharmacology and Physiology at UMSOM. Dr. Nagalo comes to UMSOM from the University of Arkansas for Medical Sciences where he served as Assistant Professor of Experimental Pathology in the Department of Pathology and Co-leader of the Cancer Therapeutics Program at the Winthrop P. Rockefeller Cancer Institute.

We are excited for Dr. Nagalo to bring his research expertise in translational virotherapy, and gene therapy for patients with advanced hepatocellular carcinoma and pancreatic cancers to UMGCCC, with a strong commitment to expanding access to innovative and cost-effective cancer treatments and advancing care and research for patients facing these challenging diseases. His work has been published in journals including Advanced Materials, Science Advances, Hepatology, Frontiers in Immunology, JCO Precision Oncology, and cited over 1,300 times. He has one issued patent and three provisional patents. Promising findings from his lab have led to highly translational clinical trials in patients including an ongoing trial testing the efficacy of intratumoral injection of standard MMR childhood vaccine in patients with pancreas cancer.

Dr. Nagalo is an active mentor and the recipient of numerous honors, including the prestigious NIH Director’s New Innovator Award, the NCI Early Investigator Advancement Program (EIAP) Scholar designation in 2024, and the AACR Career Development Award in 2022. He earned his PhD in molecular biology and Bachelor of Science in biochemistry from the University of Ouaga-JKZ in Burkina Faso, West Africa. He served as a post-doctoral fellow at the Mayo Clinic in Rochester, Minnesota and Scottsdale, Arizona.